tradingkey.logo

Ensign Group Inc

ENSG
180.310USD
-2.390-1.31%
Close 10/30, 16:00ETQuotes delayed by 15 min
10.40BMarket Cap
32.22P/E TTM

Ensign Group Inc

180.310
-2.390-1.31%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Ensign Group Inc

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Ensign Group Inc's Score

Industry at a Glance

Industry Ranking
1 / 78
Overall Ranking
12 / 4621
Industry
Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 5 analysts
Buy
Current Rating
182.400
Target Price
-0.16%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Ensign Group Inc Highlights

StrengthsRisks
The Ensign Group, Inc. is a holding company with independent subsidiaries that provide health care services across the post-acute care continuum and engages in the ownership, acquisition, development and leasing of skilled nursing, senior living and other healthcare-related properties and ancillary businesses. Its segments include Skilled Services and Standard Bearer. The Skilled Services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. The Company's portfolio includes approximately 334 healthcare operations, 30 of which also include senior living operations, across 15 states. It offers healthcare facilities in Alabama, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 40.82% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 4.26B.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 4.65%.
Overvalued
The company’s latest PE is 31.83, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 56.01M shares, decreasing 2.20% quarter-over-quarter.
Held by Wasatch Global Investors
Star Investor Wasatch Global Investors holds 3.56M shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-30

The company's current financial score is 9.19, which is higher than the Healthcare Providers & Services industry's average of 7.24. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 1.23B, representing a year-over-year increase of 18.48%, while its net profit experienced a year-over-year increase of 18.86%.

Score

Industry at a Glance

Previous score
9.19
Change
0

Financials

10.00

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

8.80

Operational Efficiency

8.10

Growth Potential

10.00

Shareholder Returns

9.05

Ensign Group Inc's Company Valuation

Currency: USD Updated: 2025-10-30

The company’s current valuation score is 6.11, which is lower than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 31.83, which is 20.58% below the recent high of 38.39 and 36.39% above the recent low of 20.25.

Score

Industry at a Glance

Previous score
6.11
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 1/78
No Data

Earnings Forecast

Currency: USD Updated: 2025-10-30

The company’s current earnings forecast score is 8.40, which is higher than the Healthcare Providers & Services industry's average of 7.60. The average price target for Ensign Group Inc is 177.00, with a high of 205.00 and a low of 170.00.

Score

Industry at a Glance

Previous score
8.40
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 5 analysts
Buy
Current Rating
182.400
Target Price
-0.16%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

64
Total
7
Median
9
Average
Company name
Ratings
Analysts
Ensign Group Inc
ENSG
5
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
26
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
22
1
2
3
...
13

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-30

The company’s current price momentum score is 9.03, which is higher than the Healthcare Providers & Services industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 190.20 and the support level at 168.46, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.24
Change
-0.21

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.661
Neutral
RSI(14)
53.653
Neutral
STOCH(KDJ)(9,3,3)
51.578
Sell
ATR(14)
3.718
High Vlolatility
CCI(14)
-62.887
Neutral
Williams %R
59.386
Sell
TRIX(12,20)
0.331
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
184.240
Sell
MA10
184.195
Sell
MA20
180.556
Sell
MA50
174.298
Buy
MA100
163.001
Buy
MA200
148.747
Buy

Institutional Confidence

Currency: USD Updated: 2025-10-30

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 97.07%, representing a quarter-over-quarter decrease of 0.53%. The largest institutional shareholder is The Vanguard, holding a total of 6.12M shares, representing 10.60% of shares outstanding, with 1.38% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
6.35M
-2.17%
The Vanguard Group, Inc.
Star Investors
6.12M
+0.53%
Wasatch Global Investors Inc
Star Investors
3.56M
+5.95%
State Street Investment Management (US)
2.08M
-1.62%
Capital Research Global Investors
1.88M
--
Capital World Investors
1.75M
--
Fidelity Management & Research Company LLC
1.76M
+2.18%
Geode Capital Management, L.L.C.
1.44M
+1.43%
Baillie Gifford & Co.
Star Investors
1.44M
+51.92%
Fuller & Thaler Asset Management Inc.
1.20M
-10.11%
1
2

Risk Assessment

Currency: USD Updated: 2025-10-30

The company’s current risk assessment score is 9.43, which is higher than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 0.94. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
9.43
Change
0
Beta vs S&P 500 index
0.94
VaR
+2.49%
240-Day Maximum Drawdown
+19.43%
240-Day Volatility
+28.35%

Return

Best Daily Return
60 days
+2.13%
120 days
+8.92%
5 years
+10.01%
Worst Daily Return
60 days
-2.61%
120 days
-3.14%
5 years
-8.70%
Sharpe Ratio
60 days
+3.39
120 days
+2.67
5 years
+0.73

Risk Assessment

Maximum Drawdown
240 days
+19.43%
3 years
+23.57%
5 years
+27.96%
Return-to-Drawdown Ratio
240 days
+1.09
3 years
+1.27
5 years
+0.83
Skewness
240 days
-0.14
3 years
-0.06
5 years
+0.21

Volatility

Realised Volatility
240 days
+28.35%
5 years
+30.29%
Standardised True Range
240 days
+1.88%
5 years
+1.50%
Downside Risk-Adjusted Return
120 days
+542.99%
240 days
+542.99%
Maximum Daily Upside Volatility
60 days
+11.97%
Maximum Daily Downside Volatility
60 days
+16.78%

Liquidity

Average Turnover Rate
60 days
+0.69%
120 days
+0.73%
5 years
--
Turnover Deviation
20 days
+3.52%
60 days
+5.09%
120 days
+11.07%

Peer Comparison

Healthcare Providers & Services
Ensign Group Inc
Ensign Group Inc
ENSG
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
Encompass Health Corp
EHC
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
Natera Inc
NTRA
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Chemed Corp
Chemed Corp
CHE
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Alignment Healthcare Inc
Alignment Healthcare Inc
ALHC
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Surgery Partners Inc
Surgery Partners Inc
SGRY
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI